
There is increasing appreciation that multiple sclerosis zzso can begin in childhood or adolescence, but pediatric zzso continues to be a rare entity, with an estimated 2 to zzso of patients with zzso experiencing their first clinical symptoms before age zzso A prompt diagnosis of pediatric zzso is important to zzso overall management of both the physical and social impact of the zzso The widespread use of zzso therapies zzso for zzso in adults, as early as following an initial isolated episode, has led to the use of zzso in children and adolescents with zzso However, it is imperative to distinguish pediatric zzso from other childhood zzso inflammatory zzso disorders such as acute zzso zzso Although increasing evidence suggests a slower disease course in children with zzso compared to adults, significant disability can still accumulate by early zzso Furthermore, associated zzso deficits can impair both academic and zzso function at a critical juncture in a young person's zzso This article reviews the clinical zzso zzso zzso findings, disease course, zzso zzso and zzso of pediatric zzso zzso adult zzso Further research of pediatric zzso may advance our understanding of zzso zzso in general, as well as improve the long-term health care outcomes of children and adolescents diagnosed with zzso 

